Kt/V urea does not tell it all

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1284-1287

  Basile, Carlo ^a   Lomonte, Carlo ^a  

^a MIULLI GENERAL HOSPITAL   (Italy)

Author keywords

dialysis adequacy; haemodialysis; Kt V urea; protein bound solutes; uraemic toxin

Indexed keywords

HOMOCYSTEINE; INDOLE DERIVATIVE; PARA CRESOL; PHENOL DERIVATIVE; UREA; UREMIC TOXIN;

ARTICLE; BLOOD FLOW; DIALYSATE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; MEMBRANE PERMEABILITY; MORTALITY; PRIORITY JOURNAL; PROTEIN BINDING; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SOLUTE; THERAPY EFFECT; TISSUE DISTRIBUTION; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; UREMIA;

DIALYSIS SOLUTIONS; HUMANS; PROTEINS; RENAL DIALYSIS; UREA;

EID: 84859329826     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr786     Document Type: Article

References (51)

1. Sirich TL, Luo FJG, Plummer NS et al. Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant 2012; 27: 1574-1579
2. Sargent JA, Gotch FA. The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int 1975; 7 (Suppl 2): S35-S44
3. Parker TF 3rd, Husni L, Huang W et al. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-680 (Pubitemid 24138420)
4. Lowrie EG, Laird NM, Parker TF et al. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-1181 (Pubitemid 12237476)
5. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534 (Pubitemid 15248043)
6. Keshaviah P. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int 1993; 40 (Suppl): S28-S38
7. Meyer TW, Sirich TL, Hostetter TH. Dialysis cannot be dosed. Semin Dial 2011; 24: 471-479
8. Eloot S, Torremans A, De Smet R et al. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 2005; 67: 1566-1575 (Pubitemid 40463137)
9. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019 (Pubitemid 35461657)
10. Lowrie EG, Chertow GM, Lew NL et al. The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 1999; 56: 729-737 (Pubitemid 29353174)
11. Lowrie EG, Li Z, Ofsthun N et al. Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 2002; 62: 1891-1897 (Pubitemid 35286301)
12. Salahudeen AK, Dykes P, May W. Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 1339-1344 (Pubitemid 36826955)
13. Sarkar SR, Kuhlmann MK, Kotanko P et al. Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int 2006; 70: 1832-1839 (Pubitemid 44684816)
14. Sarkar SR, Kotanko P, Heymsfeld SB et al. Quest for V: body composition could determine dialysis dose. Semin Dial 2007; 20: 379-382
15. Spalding EM, Chandna SM, Davenport A et al. Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int 2008; 74: 348-355 (Pubitemid 352001247)
16. Lowrie EG, Li Z, Ofsthun N et al. The online measurement of hemodialysis dose (Kt): clinical outcome as a function of body surface area. Kidney Int 2005; 68: 1344-1354 (Pubitemid 43246456)
17. Miffin MD, St Jeor ST, Hill LA et al. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990; 51: 241-247
18. Gallagher D, Albu J, He Q et al. Small organs with a high metabolic rate explain lower resting energy expenditure in African Americans than in white adults. Am J Clin Nutr 2006; 83: 1062-1067 (Pubitemid 44713105)
19. Johonson TN, Tucker GT, Tanner MS et al. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl 2005; 11: 1481-1493 (Pubitemid 43072624)
20. Basile C, Vernaglione L, Lomonte C et al. Comparison of alternative methods for scaling dialysis dose. Nephrol Dial Transplant 2010; 25: 1232-1239
21. United States Renal Data System: 2007 Annual Data Report: Atlas of End Stage Renal Diseases in the United States, Chapter 5, Clinical Indicators, p. 124; Chapter 6, Morbidity & Mortality, p. 138.
22. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007; http://m.usrds.org
23. Saran R, Bragg-Gresham JL, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222-1228
24. Shinzato T, Nakai S, Akiba T et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12: 884-888 (Pubitemid 27216307)
25. Charra B, Terrat JC, Vanel T et al. Long thrice weekly hemodialysis: the Tassin experience. Int J Artif Organs 2004; 27: 265-283 (Pubitemid 38765371)
26. Marshall MR, Byrne BG, Kerr PG et al. Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 2006; 69: 1229-1236
27. Suri RS, Nesrallah GE, Mainra R et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 2006; 1: 33-42
28. Walsh M, Culleton B, Tonelli M et al. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 2005; 67: 1500-1508 (Pubitemid 40463127)
29. Ok E, Duman S, Asci G et al. Comparison of 4-and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis. Nephrol Dial Transplant 2011; 26: 1287-1296
30. Eloot S, Van Biesen W, Dhondt A et al. Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 2008; 73: 765-770 (Pubitemid 351323256)
31. Basile C, Libutti P, Di TuroALet al. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dial Transplant 2011; 26: 1296-1303
32. Zsom L, Zsom M, Fulop T et al. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification. Semin Dial 2008; 21: 395-400
33. Basile C, Libutti P, Di Turo AL et al. Haemodynamic stability in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dial Transplant 2011; 26: 252-258
34. Shoji T, Tsubakihara Y, Fujii M et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66: 1212-1220 (Pubitemid 39121031)
35. Burton JO, Jefferies HJ, Selby NM et al. Hemodialysis-induced cardiac injury: determinants and associate outcomes. Clin J Am Soc Nephrol 2009; 4: 914-920
36. Movilli E, Gaggia P, Zubani R et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007; 22: 3547-3552
37. Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011; 79: 250-257
38. Chertow GM, KurellaM, Lowrie EG. The tortoise and hare on hemodialysis: does slow and steady win the race? Kidney Int 2006; 70: 24-25 (Pubitemid 44000116)
39. Suri RS, Garg AX, Chertow GMet al. Frequent Hemodialysis Network (FHN) randomized trials: Study design. Kidney Int 2007; 71: 349-359 (Pubitemid 46227095)
40. Chertow GM, Levin NW et al. FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363: 2287-2300
41. Rocco MV, Lockridge RS Jr, Beck GJ et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011; 80: 1080-1091
42. De Smet R, Van Kaer J, Van Vlem B et al. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003; 49: 470-478 (Pubitemid 36250208)
43. Bammens B, Evenepoel P, Keuleers H et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087 (Pubitemid 43372184)
44. Bammens B, Evenepoel P, Verbeke K et al. Removal of middle molecules and of protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 2003; 64: 2238-2243 (Pubitemid 37449560)
45. Barreto FC, Barreto DV, Liabeuf S et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 1551-1558
46. Liabeuf S, Barreto DV, Barreto FC et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 1183-1191
47. Vanholder R, Argilés A, Baurmeister U et al. Uremic toxicity: present state of the art. Int J Artif Organs 2001; 24: 695-725 (Pubitemid 33121206)
48. Lesaffer G, De Smet R, Lameire N et al. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 2000; 15: 50-57 (Pubitemid 30037930)
49. Krieter DH, Hackl A, Rodriguez A et al. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 2010; 25: 212-218
50. Meyer TW, Walther JL, Pagtalunan ME et al. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Kidney Int 2005; 68: 867-877 (Pubitemid 43323146)
51. Luo FJ, Patel KP, Marquez IO et al. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of proteinbound solutes: a pilot crossover trial. Am J Kidney Dis 2009; 53: 1042-1049